Prelude Therapeutics Announces First Quarter 2022 Financial Results and Operations Update

Go back to Prelude Therapeutics Announces First Quarter 2022 Financial Results and Operations Update
(NASDAQ: PRLD) Delayed: 5.54 +0.05 (0.91%)
Previous Close $5.49    52 Week High
Open $5.53    52 Week Low
Day High $5.82    P/E N/A 
Day Low $5.48    EPS
Volume 52,838